Reneo Pharmaceuticals Price Prediction
| RPHMDelisted Stock | USD 18.20 1.40 8.33% |
Oversold Vs Overbought
43
Oversold | Overbought |
Using Reneo Pharmaceuticals hype-based prediction, you can estimate the value of Reneo Pharmaceuticals from the perspective of Reneo Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Reneo Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Reneo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Reneo Pharmaceuticals after-hype prediction price | USD 18.38 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Reneo |
Reneo Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Reneo Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Reneo Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Reneo Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Reneo Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Reneo Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Reneo Pharmaceuticals' historical news coverage. Reneo Pharmaceuticals' after-hype downside and upside margins for the prediction period are 14.42 and 22.34, respectively. We have considered Reneo Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Reneo Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Reneo Pharmaceuticals is based on 3 months time horizon.
Reneo Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Reneo Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Reneo Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Reneo Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.61 | 3.96 | 0.18 | 0.05 | 8 Events / Month | 18 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
18.20 | 18.38 | 0.99 |
|
Reneo Pharmaceuticals Hype Timeline
Reneo Pharmaceuticals is at this time traded for 18.20. The entity has historical hype elasticity of 0.18, and average elasticity to hype of competition of -0.05. Reneo is forecasted to increase in value after the next headline, with the price projected to jump to 18.38 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 0.99%, whereas the daily expected return is at this time at 0.61%. The volatility of related hype on Reneo Pharmaceuticals is about 4554.0%, with the expected price after the next announcement by competition of 18.15. Net Loss for the year was (77.39 M) with profit before overhead, payroll, taxes, and interest of 0. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.Reneo Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Reneo Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Reneo Pharmaceuticals' future price movements. Getting to know how Reneo Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Reneo Pharmaceuticals may potentially react to the hype associated with one of its peers.
Reneo Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Reneo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Reneo using various technical indicators. When you analyze Reneo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Reneo Pharmaceuticals Predictive Indicators
The successful prediction of Reneo Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Reneo Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Reneo Pharmaceuticals based on analysis of Reneo Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Reneo Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Reneo Pharmaceuticals's related companies.
Story Coverage note for Reneo Pharmaceuticals
The number of cover stories for Reneo Pharmaceuticals depends on current market conditions and Reneo Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Reneo Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Reneo Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Reneo Pharmaceuticals Short Properties
Reneo Pharmaceuticals' future price predictability will typically decrease when Reneo Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Reneo Pharmaceuticals often depends not only on the future outlook of the potential Reneo Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Reneo Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.7 M | |
| Cash And Short Term Investments | 103 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Reneo Stock
If you are still planning to invest in Reneo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Reneo Pharmaceuticals' history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets |